By The Hon. Jillian Skinner, AM, former NSW Minister for Health. This article was originally published by News Corp.
Macular Disease Foundation Australia calls on next Federal Government to bulk-bill sight-saving eye injections for pensioners.
We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment pegcetacoplan (SYFOVRE®) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
The launch of the new Elisabeth Macdonald Memorial Award coincides with World Sight Day (9 October 2025) and marks the beginning of MDFA’s 25th anniversary year.
Welcome to the latest edition of Vision Voice.
National peak body Macular Disease Foundation Australia (MDFA) has launched Eye Connect – Australia’s first
MDFA has received a positive response from the people participating in our new Eye Connect support service.
Macular Disease Foundation Australia (MDFA) has launched its new Research Impact Report, which showcases the groundbreaking projects our organisation has funded to help reduce the impact of macular disease.